Primo Nutraceuticals Inc.
Primo Nutraceuticals Inc. (BUGVF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
bugvf · pe ratio · data through Jul 31, 2019
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Primo Nutraceuticals Inc. (BUGVF) measures how much investors pay for each dollar of the company's trailing earnings. BUGVF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.88.
Source: FMP · /ratios-ttm · /analyst-estimates · 2019-07-31
PE Ratio History
2016 – 2019 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Primo Nutraceuticals Inc.You BUGVF | $0M | N/A | — | -$0.88 |
 The Greenrose Holding Company Inc. GNRS | $0M | 2.91x | — | $1.12 |
 Green Hygienics Holdings Inc. GRYN | $0M | N/A | — | -$0.20 |
 LifeHOUSE Holdings, LLC LHRP | $0M | N/A | — | — |
 QMed, Inc. QMED | $0M | N/A | — | — |
 Refocus Group, Inc. RFCS | $0M | N/A | — | — |
 Response Oncology, Inc. ROIX | $0M | N/A | — | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2019-07-31Latest FY2019 | — | $-0.88 | — | |
2018-07-31 FY2018 | — | $0.00 | — | |
2017-07-31 FY2017 | — | $0.00 | — | |
2016-07-31 FY2016 | — | $0.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Primo Nutraceuticals Inc. (BUGVF) measures how much investors pay for each dollar of the company's trailing earnings. BUGVF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.88.
Frequently asked questions
BUGVF pe ratio · 6 questionsBUGVF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.88. Data sourced from Financial Modeling Prep via BUGVF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Primo Nutraceuticals Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09